MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1006/mthe.2002.0580

Медицинская библиотека · Molecular therapy : the journal of the American Society of Gene Therapy · 2002

Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors.

Fraites Thomas J, Schleissing Mary R, Shanely R Andrew, Walter Glenn A, Cloutier Denise A, Zolotukhin Irene, Pauly Daniel F, Raben Nina, Plotz Paul H, Powers Scott K, Kessler Paul D, Byrne Barry J

СтатьяПоддержка исследования: вне правительства СШАПоддержка службы здравоохранения СШАПеревод пока не подготовлен

Аннотация

Pompe disease is a lysosomal storage disease caused by the absence of acid alpha-1,4 glucosidase (GAA). The pathophysiology of Pompe disease includes generalized myopathy of both cardiac and skeletal muscle. We sought to use recombinant adeno-associated virus (rAAV) vectors to deliver functional GAA genes in vitro and in vivo. Myotubes and fibroblasts from Pompe patients were transduced in vitro with rAAV2-GAA. At 14 days postinfection, GAA activities were at least fourfold higher than in their respective untransduced controls, with a 10-fold increase observed in GAA-deficient myotubes. BALB/c and Gaa(-/-) mice were also treated with rAAV vectors. Persistent expression of vector-derived human GAA was observed in BALB/c mice up to 6 months after treatment. In Gaa(-/-) mice, intramuscular and intramyocardial delivery of rAAV2-Gaa (carrying the mouse Gaa cDNA) resulted in near-normal enzyme activities. Skeletal muscle contractility was partially restored in the soleus muscles of treated Gaa(-/-) mice, indicating the potential for vector-mediated restoration of both enzymatic activity and muscle function. Furthermore, intramuscular treatment with a recombinant AAV serotype 1 vector (rAAV1-Gaa) led to nearly eight times normal enzymatic activity in Gaa(-/-) mice, with concomitant glycogen clearance as assessed in vitro and by proton magnetic resonance spectroscopy.

Для цитирования: Fraites Thomas J, Schleissing Mary R, Shanely R Andrew, Walter Glenn A, Cloutier Denise A, Zolotukhin Irene, Pauly Daniel F, Raben Nina, Plotz Paul H, Powers Scott K, Kessler Paul D, Byrne Barry J. Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors.. Molecular therapy : the journal of the American Society of Gene Therapy. 2002. DOI: 10.1006/mthe.2002.0580.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.